| Relationship between β-lactamase production, outer membrane protein and penicillin-binding protein profiles on the activity of carbapenems against clinical isolates of … F Fernández-Cuenca, L Martínez-Martínez, MC Conejo, JA Ayala, ... Journal of Antimicrobial Chemotherapy 51 (3), 565-574, 2003 | 434 | 2003 |
| Biofilm formation in Acinetobacter baumannii: associated features and clinical implications J Rodríguez‐Baño, S Marti, S Soto, F Fernández‐Cuenca, JM Cisneros, ... Clinical microbiology and infection 14 (3), 276-278, 2008 | 350 | 2008 |
| Nosocomial outbreak of infection with pan–drug-resistant Acinetobacter baumannii in a tertiary care university hospital R Valencia, LA Arroyo, M Conde, JM Aldana, MJ Torres, ... Infection Control & Hospital Epidemiology 30 (3), 257-263, 2009 | 300 | 2009 |
| Contribution of efflux pumps, porins, and β-lactamases to multidrug resistance in clinical isolates of Acinetobacter baumannii C Rumbo, E Gato, M López, C Ruiz de Alegría, F Fernández-Cuenca, ... Antimicrobial agents and chemotherapy 57 (11), 5247-5257, 2013 | 241 | 2013 |
| Clinical features and epidemiology of Acinetobacter baumannii colonization and infection in Spanish hospitals J Rodríguez-Baño, JM Cisneros, F Fernández-Cuenca, A Ribera, J Vila, ... Infection Control & Hospital Epidemiology 25 (10), 819-824, 2004 | 237 | 2004 |
| Detección fenotípica de mecanismos de resistencia en microorganismos gramnegativos F Navarro, J Calvo, R Cantón, F Fernández-Cuenca, B Mirelis Enfermedades Infecciosas y microbiología clínica 29 (7), 524-534, 2011 | 225 | 2011 |
| Risk-factors for the acquisition of imipenem-resistant Acinetobacter baumannii in Spain: a nationwide study JM Cisneros, J Rodriguez-Bano, F Fernández-Cuenca, A Ribera, J Vila, ... Clinical microbiology and infection 11 (11), 874-879, 2005 | 176 | 2005 |
| Contribution of OqxAB efflux pumps to quinolone resistance in extended-spectrum-β-lactamase-producing Klebsiella pneumoniae JM Rodríguez-Martínez, P Díaz de Alba, A Briales, J Machuca, M Lossa, ... Journal of Antimicrobial Chemotherapy 68 (1), 68-73, 2013 | 154 | 2013 |
| Long-term control of hospital-wide, endemic multidrug-resistant Acinetobacter baumannii through a comprehensive “bundle” approach J Rodríguez-Baño, L García, E Ramírez, L Martínez-Martínez, MA Muniain, ... American journal of infection control 37 (9), 715-722, 2009 | 123 | 2009 |
| High prevalence of carbapenem-hydrolysing oxacillinases in epidemiologically related and unrelated Acinetobacter baumannii clinical isolates in Spain M Ruiz, S Marti, F Fernandez-Cuenca, A Pascual, J Vila Clinical microbiology and infection 13 (12), 1192-1198, 2007 | 114 | 2007 |
| Monotherapy versus combination therapy for sepsis due to multidrug-resistant Acinetobacter baumannii: analysis of a multicentre prospective cohort LE López-Cortés, JM Cisneros, F Fernández-Cuenca, G Bou, M Tomas, ... Journal of antimicrobial chemotherapy 69 (11), 3119-3126, 2014 | 113 | 2014 |
| Colistin resistance in a clinical Acinetobacter baumannii strain appearing after colistin treatment: effect on virulence and bacterial fitness R López-Rojas, MJ McConnell, ME Jiménez-Mejías, ... Antimicrobial agents and chemotherapy 57 (9), 4587-4589, 2013 | 103 | 2013 |
| High incidence of MDR and XDR Pseudomonas aeruginosa isolates obtained from patients with ventilator-associated pneumonia in Greece, Italy and Spain as part … A Pérez, E Gato, J Pérez-Llarena, F Fernández-Cuenca, MJ Gude, ... Journal of Antimicrobial Chemotherapy 74 (5), 1244-1252, 2019 | 100 | 2019 |
| Epidemiologic and clinical impact of Acinetobacter baumannii colonization and infection: a reappraisal M Villar, ME Cano, E Gato, J Garnacho-Montero, JM Cisneros, ... Medicine 93 (5), 202-210, 2014 | 95 | 2014 |
| Activity of cefiderocol against high-risk clones of multidrug-resistant Enterobacterales, Acinetobacter baumannii, Pseudomonas aeruginosa and Stenotrophomonas maltophilia M Delgado-Valverde, MC Conejo, L Serrano, F Fernández-Cuenca, ... Journal of Antimicrobial Chemotherapy 75 (7), 1840-1849, 2020 | 90 | 2020 |
| New findings in HCV genotype distribution in selected West European, Russian and Israeli regions V Kartashev, M Döring, L Nieto, E Coletta, R Kaiser, S Sierra, A Guerrero, ... Journal of Clinical Virology 81, 82-89, 2016 | 88 | 2016 |
| Reduced susceptibility to biocides in Acinetobacter baumannii: association with resistance to antimicrobials, epidemiological behaviour, biological cost and effect … F Fernández-Cuenca, M Tomás, FJ Caballero-Moyano, G Bou, ... Journal of Antimicrobial Chemotherapy 70 (12), 3222-3229, 2015 | 81 | 2015 |
| Prevalence of ISAba1 in epidemiologically unrelated Acinetobacter baumannii clinical isolates M Ruiz, S Marti, F Fernandez-Cuenca, A Pascual, J Vila FEMS microbiology letters 274 (1), 63-66, 2007 | 79 | 2007 |
| Overproduction of Outer Membrane Protein A by Acinetobacter baumannii as a Risk Factor for Nosocomial Pneumonia, Bacteremia, and Mortality Rate Increase V Sánchez-Encinales, R Álvarez-Marín, ME Pachón-Ibáñez, ... The Journal of infectious diseases 215 (6), 966-974, 2017 | 76 | 2017 |
| Analysis of genes encoding penicillin-binding proteins in clinical isolates of Acinetobacter baumannii R Cayô, MC Rodríguez, P Espinal, F Fernández-Cuenca, ... Antimicrobial agents and chemotherapy 55 (12), 5907-5913, 2011 | 76 | 2011 |
